{"name":"PharmaKing","slug":"pharmaking","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[{"name":"Other","slug":"other","revenue":0,"percentOfTotal":0,"drugCount":2,"colorKey":"oncology","drugs":[{"name":"NISSEL","genericName":"NISSEL","slug":"nissel","indication":"Other","status":"phase_3"},{"name":"PENNEL","genericName":"PENNEL","slug":"pennel","indication":"Other","status":"marketed"}]},{"name":"Oncology","slug":"oncology","revenue":0,"percentOfTotal":0,"drugCount":2,"colorKey":"immunology","drugs":[{"name":"Oltipraz 1 (90mg)","genericName":"Oltipraz 1 (90mg)","slug":"oltipraz-1-90mg","indication":"Cancer chemoprevention in high-risk populations","status":"phase_3"},{"name":"Oltipraz 2 (120mg)","genericName":"Oltipraz 2 (120mg)","slug":"oltipraz-2-120mg","indication":"Hepatocellular carcinoma chemoprevention in patients with chronic hepatitis B","status":"phase_3"}]}],"pipeline":[{"name":"NISSEL","genericName":"NISSEL","slug":"nissel","phase":"phase_3","mechanism":"NISSEL's mechanism of action is not publicly available.","indications":[],"catalyst":""},{"name":"Oltipraz 1 (90mg)","genericName":"Oltipraz 1 (90mg)","slug":"oltipraz-1-90mg","phase":"phase_3","mechanism":"Oltipraz is an organosulfur compound that induces phase II detoxification enzymes and antioxidant pathways, enhancing cellular defense against oxidative stress and carcinogens.","indications":["Cancer chemoprevention in high-risk populations","Aflatoxin-induced hepatocellular carcinoma prevention"],"catalyst":""},{"name":"Oltipraz 2 (120mg)","genericName":"Oltipraz 2 (120mg)","slug":"oltipraz-2-120mg","phase":"phase_3","mechanism":"Oltipraz is an organosulfur compound that induces phase II detoxification enzymes and antioxidant pathways to protect cells from oxidative stress and carcinogenic damage.","indications":["Hepatocellular carcinoma chemoprevention in patients with chronic hepatitis B","Aflatoxin-related cancer prevention"],"catalyst":""},{"name":"PENNEL","genericName":"PENNEL","slug":"pennel","phase":"marketed","mechanism":"Small molecule","indications":[],"catalyst":""}],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMizAFBVV95cUxOWUVGTHdmRVFUQm9iMmlIdTFjdDROMWtRLW1NdVJJLUw3emRaVktrMk9tYkFvY1JTUXlWdEZzN3NuUVdEcXBJbFBET3pXT0p0OGRxNzJMMzhTVlVabWs4M0ZIYzJaSkFGbEtqZldLWHZTbzdtVWItRmYxYlFVMWZJeGJGaVQ3djFxQVBZTWRyZllzNl8xOTYzbW5qeDV3TkkwZXRqeXphcnI1TkFpUXZlOTVDNnVnUkhGTUlGLUhPYlowUWlyVElxV0RSYV8?oc=5","date":"2025-12-03","type":"pipeline","source":"AFR","summary":"Dennis Bastas’ rise from aspiring car designer to $5b pharma king - AFR","headline":"Dennis Bastas’ rise from aspiring car designer to $5b pharma king","sentiment":"neutral"},{"url":"https://news.google.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?oc=5","date":"2025-11-26","type":"pipeline","source":"Asianet Newsable","summary":"Who Is Rama Raju Mantena? Meet the Pharma King Behind Udaipur’s Grand ₹75-80-Crore Wedding - Asianet Newsable","headline":"Who Is Rama Raju Mantena? Meet the Pharma King Behind Udaipur’s Grand ₹75-80-Crore Wedding","sentiment":"neutral"},{"url":"https://news.google.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?oc=5","date":"2025-11-24","type":"pipeline","source":"India Today","summary":"Who is Rama Raju Mantena, pharma king behind Udaipur's star-studded wedding? - India Today","headline":"Who is Rama Raju Mantena, pharma king behind Udaipur's star-studded wedding?","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi4AJBVV95cUxORFRPWWhiN09YUlpyMjVRanR6dGF5WXNkdjZsdGRoa2paRHVzLWRyWm1wblB4ZWFISTl5VFBUSEFoSWxOdUIwOG8tbEdvNjF6RkxiYWdpQjVTVmdaa0hoeGktZFg4b0Y0elIxNEx6am56azN1dGJmUFEzeDVWRlg0NWdnSHFORUktbXl5VHVqNHFwbGNZT3NKbk1meXpoMkJxcVlXdjR3eWY1UGFJQndjdlVTdWpna2N2dURnYnpMa3BZbWkzNi1Ebjh3ZnhCSkVJem1jcDdlN28zSzFlVzBiRjE4NGJaWUd3YXFVLVlGSmdLNno5UXVhTFZTaWdxMVRlQUlOdkpYelhoblplYTRXUFBFWXdueXBzVFJzTkgyRzVWWTdsUXE1bVRkM08wTk9kSEp3d0pUT25CLXI3QktGS05ER0tMVU9mQ3JkT3R4dmJfMndQX2lVRF9mODhlSm14?oc=5","date":"2025-11-24","type":"pipeline","source":"Zee News","summary":"Meet The Man Who Donated 28 kg Gold Necklace At Tirupati Temple, Owns Rs 4,000,000,000 Property With Private Beach In THIS Country; Check His Net Worth And Education - Zee News","headline":"Meet The Man Who Donated 28 kg Gold Necklace At Tirupati Temple, Owns Rs 4,000,000,000 Property With Private Beach In TH","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi1wJBVV95cUxQckd0aWoxdXFlQ2hLVmVsbTZITmlLSDVWNEJvcDdBa1pqWDd2cVdCYjVFOEdxRU9tUlB2MGtFeEZBZ29HbU1rdkUtNEZSZUM0NExIaTJPTERFaWtEeXRyR3dvNnlnTW1iYzFnNnFseHZUZ1VMRmNmdE5kTlpMRGRYMlJ6aFluZDVFbzJhYW8wU1l4elE2bElSOWFlc0FPcW5HYlFVUWU4OExkNklxemVLQURkSUZBMlFUWmhwYUpSNUViRWNLYUVOdjJmM2ljaVFWZXAzMFhmR2lUdUs0OTdzcEU4TURTcDVPOHdlT2s5RG9ET1VPcWFuS0FoYnpHamIzVmlnQ21CV3VnblhrNlNUUzUtOGl4dW9QakJiYS1aanREN3FzWDJpOTVNVUlFNDd3Nkk0dkRtWDJoclFNXzd0WjQ4QlNyZkZJTmgxMjZVMkRfRHo1MHdz?oc=5","date":"2025-11-22","type":"pipeline","source":"DNA India","summary":"Who is Vamsi Gadiraju? 'Groom of the year', who is set to marry US billionaire's daughter Netra Mantena in lavish Udaipur wedding, featured in Forbes 30 under 30 list, his business is... - DNA India","headline":"Who is Vamsi Gadiraju? 'Groom of the year', who is set to marry US billionaire's daughter Netra Mantena in lavish Udaipu","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMicEFVX3lxTFBOLS1kbVZtOFpGdUZ1TGloZ3JGV1lhdGE1eUVxRXNQRlRocG80M1ZIZlFSS2xSV3VKUU9faTVBSW9hdW5icXU3UktwbFdaUkk1d3lXX0FuRWNlQ0hWVU1RYmdoOVBWUGlHeXFmODZJVzY?oc=5","date":"2024-02-08","type":"pipeline","source":"Think Business","summary":"Pharma king: Chanelle bought by Exponent - Think Business","headline":"Pharma king: Chanelle bought by Exponent","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMisAFBVV95cUxQeThiOXV0UGhkUjVrOE1CcExUcWJjN25vOEpGcVNTMGtLSVNPSF9DRnpGSzRkUkxnd3ptSzc5bzZLbXdfbnE3U1lJck00WlpMcVlxT1hJeGJqRXFMTDJ3VDB3aUJiNUowUUtXRS0yWm1LZEV1NHBYUGZrRmhqTzVhWmRVc1d1Yy1XZGh6bll6YWY2a21rMXJNbDNtTGw2Tnpqem51U3NKYWVGNXh4TGxGNA?oc=5","date":"2023-10-08","type":"pipeline","source":"The Times","summary":"Pharma king Mulligan closes on cancer care stake - The Times","headline":"Pharma king Mulligan closes on cancer care stake","sentiment":"neutral"},{"url":"https://news.google.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?oc=5","date":"2023-03-22","type":"deal","source":"The Australian","summary":"‘I’ve never done a bad deal’: Pharma king Bastas - The Australian","headline":"‘I’ve never done a bad deal’: Pharma king Bastas","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi3AFBVV95cUxQOGhzRUF6cl9qQmQyQnRwNVJjc1JMeHFMbUpJMElybzNPWkFaaHFBM0NLdXNhSFBCblZNVXBZbTdiYlF0SzFHb0tNZWlCOGk1enFFSkpDekR1aWs3MTE3cWFQWGx2T0M5NUxIOGpfZW9MQVhwczN4R1JtOEloUlhENklLYjRtREo2bzVIUlcyWU5PY2pNcFFjOVhJQjRYZEJtMFRDR0kyVEdCSDdMUWxLMlVrUXJuclJidjFuSWFJRUZWY0tUaHNUXzUxem9kNUtLOVZwaVhHbEtIOHFZ?oc=5","date":"2021-09-17","type":"pipeline","source":"Dallas News","summary":"The pharma king's gambit: J&J may use Texas law to reduce payouts to ovarian cancer victims - Dallas News","headline":"The pharma king's gambit: J&J may use Texas law to reduce payouts to ovarian cancer victims","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMibkFVX3lxTE8zWlhkVm81Si0tTWhMRVExZnQtdE9ISnNNMVl3eTZnRXk1cHdrbHRGUXVVQ1J0dkJpck51R2x4b24zSDAwLUtQcDFEVTlLU2ZSNmZYQmhTNFl4c0xFS010bUhQTXJ2MERjNzR4dERB0gFyQVVfeXFMT1cxRjd5bXI3T3JzdzlrbmRaSmd5MjBPZndrRTJId0w5dGNqUnplcXlONWVHdFdOQ0d2X2NmUkViN3FSN3hMazVITFZMOUhwNE5UZEFjS3IxUDJkclA2YmwzWjJZR0RpVWlGeW5tSzhIY0h3?oc=5","date":"2021-01-29","type":"patent","source":"koreabiomed.com","summary":"Off-patent drugs Godex, Atozet on a roll without generics - koreabiomed.com","headline":"Off-patent drugs Godex, Atozet on a roll without generics","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMipgFBVV95cUxPdFk0aU82aGZ4SlBzNzd5Z1E1OWw2b2U5VU1IQ2VjeS1nVzFvb1QwU2RqUThKU1pVLUFQc3VDWmdLZ3lzakNVT0R6RHM0VFpqVjE2aTFUMDh4VDVlZWdtU3NfRm5fVEpZTUFfSmpFeE5MU2VwMF9yeEgxY2pCcm5uV2t5VjNMNHVLemxOSmdIanp1VE50NVVaVjctQlVobnpPVTZwOE13?oc=5","date":"2020-11-19","type":"pipeline","source":"New York Post","summary":"Pharma king sets Brooklyn townhouse record in pursuit of mega-mansion - New York Post","headline":"Pharma king sets Brooklyn townhouse record in pursuit of mega-mansion","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMickFVX3lxTFBYbkJ5N1RESGl2ai1GRzdiZi1DbmpUbVRPOENvZUx2bVpHWVEybEZKM0pVcE1BZ2k4Q1VlRlRzYmpOWFVMek1EYmwxeHF2cXhqYUQ5T0xFQ1lJeDJkYVNwNkFaVVBzc0ZzMUVaLXlzZ1Iwd9IBd0FVX3lxTFA2REhpMTd5Sk1qallsZTJDb2xNZE1TZnh4WHozLU0yZlczemhTYUdVQUgybHlBQmVEcFZGTm96TDhHYjlXN1JhdkI2NHVfSldVQy1hb2hkbHgtVmQ1NmN3ZmlWUnNDd2taTDFPM3NIdEhkajZEN2Nv?oc=5","date":"2010-09-07","type":"pipeline","source":"observer.com","summary":"Stewie Rah Rah, Pharma’s King of Fun - observer.com","headline":"Stewie Rah Rah, Pharma’s King of Fun","sentiment":"neutral"}],"patents":[],"drugCount":4,"phaseCounts":{"phase_3":3,"marketed":1},"enrichmentLevel":2,"visitCount":1,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}